ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers

…, A Gonzalez, R Fang, EJ Mark, JM Batten… - Journal of clinical …, 2012 - ascopubs.org
Purpose Chromosomal rearrangements involving the ROS1 receptor tyrosine kinase gene
have recently been described in a subset of non–small-cell lung cancers (NSCLCs). Because …

[HTML][HTML] Clinical sensitivity and interpretation of PCR and serological COVID‐19 diagnostics for patients presenting to the hospital

…, LL Ritterhouse, SE Turbett, J Batten… - The FASEB …, 2020 - ncbi.nlm.nih.gov
The diagnosis of COVID‐19 requires integration of clinical and laboratory data. Severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) diagnostic assays play a central role in …

IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity

…, GM Baker, KS Cole, A Von Deimling, JM Batten… - Cancer research, 2016 - AACR
Solid papillary carcinoma with reverse polarity (SPCRP) is a rare breast cancer subtype with
an obscure etiology. In this study, we sought to describe its unique histopathologic features …

Recurrent chromosomal copy number alterations in sporadic chordomas

…, GP Nielsen, AE Rosenberg, D Thomas, JM Batten… - PloS one, 2011 - journals.plos.org
The molecular events in chordoma pathogenesis have not been fully delineated, particularly
with respect to copy number changes. Understanding copy number alterations in chordoma …

Deficient DNA mismatch repair is common in Lynch syndrome-associated colorectal adenomas

…, BM Wildemore, A Ganguly, J Batten… - The Journal of Molecular …, 2009 - Elsevier
Lynch syndrome is caused by germline mutations in DNA mismatch repair (MMR) genes.
Both microsatellite instability (MSI) testing and immunohistochemical analyses (IHC) of colon …

Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment

…, AK Cosper, K Bergethon, VL Scialabba, JM Batten… - Clinical cancer …, 2013 - AACR
Purpose: Salivary duct carcinomas (SDC) are a rare and aggressive subtype of salivary gland
cancers for which cytotoxic chemotherapy has limited efficacy. We investigated whether …

DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome

…, BM Kuter, MS Bertalan, JJ Miller, JM Batten… - Acta …, 2018 - Springer
Progressive meningiomas that have failed surgery and radiation have a poor prognosis and
no standard therapy. While meningiomas are more common in females overall, progressive …

[HTML][HTML] Next-generation sequencing and fluorescence in situ hybridization have comparable performance characteristics in the analysis of pancreaticobiliary …

…, LP Le, D Dias-Santagata, D Borger, J Batten… - The Journal of Molecular …, 2016 - Elsevier
Cytological evaluation of pancreatic or biliary duct brushings is a specific, but insensitive,
test for malignancy. We compared adjunctive molecular testing with next-generation …

Genotype-targeted local therapy of glioma

…, JM Francis, ML Rinne, JM Batten… - Proceedings of the …, 2018 - National Acad Sciences
Aggressive neurosurgical resection to achieve sustained local control is essential for
prolonging survival in patients with lower-grade glioma. However, progression in many of these …

Clinical Utility of Rapid EGFR Genotyping in Advanced Lung Cancer

…, JJ Lin, SR Digumarthy, JM Batten… - JCO precision …, 2018 - ascopubs.org
Purpose Targeted therapy is the cornerstone of treatment of advanced EGFR-mutant non–small-cell
lung cancer (NSCLC). Next-generation sequencing (NGS), the preferred method for …